97
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy

, , , , , , & show all
Pages 3541-3547 | Published online: 11 Dec 2017

References

  • AsmisTRDingKSeymourLAge and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsJ Clin Oncol2008261545918165640
  • RosellRMoranTQueraltCSpanish Lung Cancer GroupScreening for epidermal growth factor receptor mutations in lung cancerN Engl J Med20093611095896719692684
  • RamseySDHowladerNEtzioniRDDonatoBChemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-MedicareJ Clin Oncol200422244971497815611512
  • LoganathanRSStoverDEShiWVenkatramanEPrevalence of COPD in women compared to men around the time of diagnosis of primary lung cancerChest200612951305131216685023
  • YoungRPHopkinsRJChristmasTBlackPNMetcalfPGambleGDCOPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEur Respir J200934238038619196816
  • HashimotoNMatsuzakiAOkadaYClinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patientsBMC Pulm Med2014141424498965
  • OsukaSHashimotoNSakamotoKWakaiKYokoiKHasegawaYRisk stratification by the lower limit of normal of FEV1/FVC for postoperative outcomes in patients with COPD undergoing thoracic surgeryRespir Investig2015533117123
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • MatsuoMHashimotoNUsamiNInspiratory capacity as a preoperative assessment of patients undergoing thoracic surgeryInteract Cardiovasc Thorac Surg201214556056422307392
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease-2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed April 17, 2017
  • IzquierdoJLResanoPEl HachemAGrazianiDAlmonacidCSanchezIMImpact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitorsInt J Chron Obstruct Pulmon Dis201491053105825336937
  • MaemondoMInoueAKobayashiKNorth-East Japan Study GroupGefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRN Engl J Med2010362252380238820573926
  • MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
  • LeeSJLeeJParkYSImpact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancerJ Thorac Oncol20149681281724807154
  • GaoYHGuanWJLiuQImpact of COPD and emphysema on survival of patients with lung cancer: a meta-analysis of observational studiesRespirology201621226927926567533
  • KatoTMoriseMAndoMCan we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?J Cancer Res Clin Oncol201614271629164027166967
  • HirschFRSpreaficoANovelloSWoodMDSimmsLPapottiMThe prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewJ Thorac Oncol20083121468148119057275
  • MatsuzakiAHashimotoNOkachiSClinical impact of the lower limit of normal of FEV1/FVC on survival in lung cancer patients undergoing thoracic surgeryRespir Investig2016543184192
  • JonesPWAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
  • CruzJMarquesAJácomeCGabrielRFigueiredoDGlobal functioning of COPD patients with and without functional balance impairment: an exploratory analysis based on the ICF frameworkCOPD201512220721625093384
  • NederJAO’DonnellCDCoryJVentilation distribution heterogeneity at rest as a marker of exercise impairment in mild-to-advanced COPDCOPD201512324925625230258
  • MörthCValachisASingle-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: a literature-based meta-analysis of randomized studiesLung Cancer201484320921424702946
  • SekineYBehniaMFujisawaTImpact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLCLung Cancer20023719510112057873
  • YabuuchiHKawanamiSKamitaniTPrediction of post-operative pulmonary function after lobectomy for primary lung cancer: a comparison among counting method, effective lobar volume, and lobar collapsibility using inspiratory/expiratory CTEur J Radiol201685111956196227776646
  • PelletierCLapointeLLeBlancPEffects of lung resection on pulmonary function and exercise capacityThorax19904574975022396230
  • HardieJABuistASVollmerWMEllingsenIBakkePSMorkveORisk of over-diagnosis of COPD in asymptomatic elderly never-smokersEur Respir J20022051117112212449163
  • LimJUYeoCDRheeCKChronic obstructive pulmonary disease-related non-small-cell lung cancer exhibits a low prevalence of EGFR and ALK driver mutationsPLoS One20151011e014230626555338
  • ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc20085454955518453370